|Stem Cell Sciences
||EPS - Basic
||Market Cap (m)
|Pharmaceuticals & Biotechnology
Real-Time news about Asset Real (London Stock Exchange): 0 recent articles
|Stem Cell Sciences Daily Update: Stem Cell Sciences is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker STEM. The last closing price for Stem Cell Sciences was 5.50p.|
Stem Cell Sciences has a 4 week average price of - and a 12 week average price of -.
The 1 year high share price is - while the 1 year low share price is currently -.
There are currently 33,516,149 shares in issue and the average daily traded volume is 0 shares. The market capitalisation of Stem Cell Sciences is £1,843,388.20.
|the_doctor: Just read up more...
I didnt realise that the plan is to sell the SC Inc shares over the next two months!
What a daft plan.
SC Inc.s share price will be impacted
It would have been better to sell the lot to SC Inc and give SCS shareholders the equivalent US shares/cash.
Maybe that cant be done given the issue of UK shareholders getting US shares??
Other than that, you'll get a fair price, since they'll be selling for cash in the US.
Re loss of control - well, last few months, it was suspended. I'd say you now have much more control :o)|
|don muang: Under present circumstances then seems Scotland was one just too many locations to be operating from. Let's see with hindsight if this was the low point for Stem in terms of share price?|
|lamanga2004: With an average of only a few thousand shares traded each day since Aug 22nd, and the share price walking itself down about 7p (or 20%) since then, can anyone give me a good reason to put my money here?
What projects do they have in the pipeline?|
|dave-w: Just had a 'negative performance indicators' warning from Dun and Bradstreet re STEM. (Want me to buy the report of course!). No response from share price.
Anybody have ay idea what this might be about?|
|samuri19: Stock seems to be consolidating at these levels. Big sells going through today
but the MM's seem to be soaking it up (some sells being offered premium price).
Maybe we have a buyer in the back-ground.
Company needs to get active and produce a steady stream of news flow. This is a real cutting edge sector to be in, but the company (at the moment) seem unable to transfer that towards the share price.
Any other views would be appreciated (if there is anyone else out there).|
|dave-w: No RNS, no press release, one 50,000 sell... and the share price jumps up a whole penny??? Wonder what's going round the MM's rumour mill?|
Stem Cell Sciences share price data is direct from the London Stock Exchange